Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Allergan to evaluate Pharmacopeia compounds in models of ocular disease

July 15, 2005

Senju scientists synthesize novel calpain inhibitors

July 13, 2005

Eyetech selects preclinical candidate in Archemix collaboration

July 7, 2005

New clinical program for intravitreal VEGF Trap for eye diseases

July 7, 2005

Novel compounds for treatment of glaucoma disclosed in patent literature

July 7, 2005

Retisert launched for chronic noninfectious uveitis

July 6, 2005

First phase III study begins for Evizon in wet AMD

July 5, 2005

Oxigene updates vascular targeting programs in ophthalmology

July 1, 2005

Genaera reaches SPA agreement on phase III trials for Evizon

June 30, 2005

Pre-NDA meeting for AzaSite

June 30, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...